INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT BY AND AMONG BAXALTA WORLD TRADE LLC BAXALTA GMBH BAXALTA HOLDING B.V. BAXTER WORLD TRADE CORPORATION BAXTER HEALTHCARE SA AND BAXTER HOLDING B.V. DATED AS OF JUNE 30, 2015International Commercial Operations Agreement • July 2nd, 2015 • Baxalta Inc • Pharmaceutical preparations • Delaware
THIS INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT, dated as of June 30, 2015, is by and among Baxalta World Trade LLC, a limited liability company organized under the laws of Delaware, United States of America (“Baxalta US”), Baxalta GmbH, a limited liability company organized under the laws of Switzerland (“Baxalta Swiss”), Baxalta Holding B.V., a private company with limited liability organized under the laws of the Netherlands (“Baxalta Netherlands” and, together with Baxalta US and Baxalta Swiss, “Baxalta Parties”), Baxter World Trade Corporation, a corporation organized under the laws of Delaware, United States of America (“Baxter US”), Baxter Healthcare SA, a stock company organized under the laws of Switzerland (“Baxter Swiss”) and Baxter Holding B.V., a private company with limited liability organized under the laws of the Netherlands (“Baxter Netherlands” and, together with Baxter US and Baxter Swiss, “Baxter Parties”).
FORM OF LUXEMBOURG INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT BY AND BETWEEN ABBOTT INVESTMENTS LUXEMBOURG S.à r.l AND ABBVIE INVESTMENTS S.à r.l DATED AS OF [·], 2012International Commercial Operations Agreement • September 4th, 2012 • AbbVie Inc. • Pharmaceutical preparations • Delaware
THIS LUXEMBOURG INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT, dated as of [·], 2012, is by and between Abbott Investments Luxembourg S.à r.l, a company organized and existing under the laws of Luxembourg (“Abbott Luxembourg”) and AbbVie Investments S.à r.l, a company organized and existing under the laws of Luxembourg (“AbbVie Luxembourg”).
FIRST AMENDMENT TO INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENTInternational Commercial Operations Agreement • February 21st, 2014 • AbbVie Inc. • Pharmaceutical preparations • Delaware
THIS FIRST AMENDMENT is made effective as of December 31, 2012 (this “First Amendment”), by and between Abbott Laboratories, an Illinois corporation (“Abbott”) and AbbVie Inc., a Delaware corporation (“AbbVie”). All capitalized terms used herein without definition shall have the meaning assigned thereto in the Agreement (as hereinafter defined), and, except as otherwise provided below, references herein to a specific Section or Schedule will refer, respectively, to the corresponding Section or Schedule of the Agreement.
LUXEMBOURG INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT BY AND BETWEEN ABBOTT INVESTMENTS LUXEMBOURG S.à r.l. AND ABBVIE INVESTMENTS S.à r.l. DATED AS OF DECEMBER 31, 2012International Commercial Operations Agreement • January 2nd, 2013 • AbbVie Inc. • Pharmaceutical preparations • Delaware
THIS LUXEMBOURG INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT, dated as of December 31, 2012, is by and between Abbott Investments Luxembourg S.à r.l., a company organized and existing under the laws of Luxembourg (“Abbott Luxembourg”) and AbbVie Investments S.à r.l., a company organized and existing under the laws of Luxembourg (“AbbVie Luxembourg”).
INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT BY AND BETWEEN ABBOTT LABORATORIES AND ABBVIE INC. DATED AS OF DECEMBER 31, 2012International Commercial Operations Agreement • January 2nd, 2013 • AbbVie Inc. • Pharmaceutical preparations • Delaware
THIS INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT, dated as of December 31, 2012, is by and between Abbott Laboratories, an Illinois corporation (“Abbott”) and AbbVie Inc., a Delaware corporation (“AbbVie”).
FORM OF INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT BY AND BETWEEN ABBOTT LABORATORIES AND ABBVIE INC. DATED AS OF [·], 2012International Commercial Operations Agreement • September 4th, 2012 • AbbVie Inc. • Pharmaceutical preparations • Delaware
THIS INTERNATIONAL COMMERCIAL OPERATIONS AGREEMENT, dated as of [·], 2012, is by and between Abbott Laboratories, an Illinois corporation (“Abbott”) and AbbVie Inc., a Delaware corporation (“AbbVie”).
